Patients should be advised that current antiretroviral therapy, including efavirenz, has not been proven to prevent the risk of transmission of HIV to others through sexual contact or blood contamination.
Patsiente peab hoiatama, et kaasaegne retroviiruste vastane ravi, sh efavirens, ei hoia ära HIV- nakkuse levimise riski seksuaalkontaktidel või vere kaudu.